LRRC4 and glioblastoma: As shown in Fig. 8e, reduced LRRC4 mRNA levels were found in recurrent GBM samples compared with GBM samples without recurrence, suggesting that the expression levels of LRRC4 may be negatively correlated with drug resistance.